Suppr超能文献

玻璃体切除术联合引流管治疗儿童无晶状体性青光眼

Management of Pediatric Aphakic Glaucoma With Vitrectomy and Tube Shunts.

作者信息

Elshatory Yasser M, Gauger Elizabeth H, Kwon Young H, Alward Wallace L M, Boldt H Culver, Russell Stephen R, Mahajan Vinit B

出版信息

J Pediatr Ophthalmol Strabismus. 2016 Nov 1;53(6):339-343. doi: 10.3928/01913913-20160818-01. Epub 2016 Sep 27.

Abstract

PURPOSE

To review the impact of vitrectomy and tube shunts on mean intraocular pressure (IOP) and number of glaucoma medications in pediatric aphakic glaucoma.

METHODS

A retrospective review of pediatric patients who underwent combined vitrectomy and glaucoma tube shunt surgery for aphakic glaucoma was conducted. Inclusion criteria were: age 18 years or younger, diagnosis of aphakic glaucoma, preoperative IOP data, and postoperative IOP data for at least 6 months. Mean IOP lowering at 1 year, number of glaucoma medications at 1 year, and surgical complications, including tube occlusion in the postoperative period, were noted.

RESULTS

The mean ± standard deviation preoperative IOP was 33.9 ± 10.6 mm Hg (range: 18 to 57 mm Hg) with a mean of three topical IOP-lowering medications. A total of 5 (36%) Ahmed and 9 (64%) Baerveldt tube shunts were placed. One of the Baerveldt tube shunt procedures was combined with revision of a traumatically dislocated tube. The mean IOP at 12 months postoperatively was 16.6 ± 5.8 mm Hg (range: 6 to 28 mm Hg; P < .01, t = 3.74, df = 13) with a mean of 2.3 glaucoma medications. There were no cases of tube occlusion, corneal decompensation, endophthalmitis, or retinal detachment over the 12 months of follow-up.

CONCLUSIONS

Combined vitrectomy and placement of a glaucoma tube shunt can be safe and effective in lowering IOP based on mean IOP values and number of glaucoma medications at 1 year. [J Pediatr Ophthalmol Strabismus. 2016;53(6):339-343.].

摘要

目的

回顾玻璃体切除术和引流管分流术对小儿无晶状体性青光眼患者平均眼压(IOP)及青光眼药物使用数量的影响。

方法

对接受玻璃体切除术联合青光眼引流管分流术治疗无晶状体性青光眼的小儿患者进行回顾性研究。纳入标准为:年龄18岁及以下、诊断为无晶状体性青光眼、术前眼压数据以及术后至少6个月的眼压数据。记录1年时平均眼压降低情况、1年时青光眼药物使用数量以及手术并发症,包括术后引流管阻塞情况。

结果

术前平均眼压±标准差为33.9±10.6 mmHg(范围:18至57 mmHg),平均使用三种局部降眼压药物。共植入5枚(36%)艾哈迈德引流管和9枚(64%)贝尔维尔德引流管。其中1例贝尔维尔德引流管手术联合外伤性脱位引流管修复术。术后12个月时平均眼压为16.6±5.8 mmHg(范围:6至28 mmHg;P <.01,t = 3.74,自由度 = 13),平均使用2.3种青光眼药物。在12个月的随访期内,未出现引流管阻塞、角膜失代偿、眼内炎或视网膜脱离病例。

结论

基于1年时的平均眼压值和青光眼药物使用数量,玻璃体切除术联合青光眼引流管分流术在降低眼压方面安全有效。[《小儿眼科与斜视杂志》。2016;53(6):339 - 343。]

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验